Neuroendocrine Cancer | Tumor

CURE’s neuroendocrine cancer page features the latest cancer news and updates on neuroendocrine cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in neuroendocrine cancer.

Do You Ever Question Your Cancer Care?

May 23rd 2022, 5:00pm

Article

I’ve always received impeccable care at my cancer center, but a recent experience made me feel like I was no longer a priority.

During the Pre-Cancer Days, My Intuition Pushed Me in the Right Direction

April 27th 2022, 5:00pm

Article

Before being diagnosed with neuroendocrine cancer, I started to live a healthier life and took notice of some concerning symptoms.

Potential FDA Cancer Drug Approvals on the Horizon This Spring

March 24th 2022, 3:02pm

Article

The Food and Drug Administration plans on reviewing multiple new cancer therapies this spring.

3 Stages of Coping With Cancer: There Are Better Days Ahead

March 3rd 2022, 6:00pm

Article

When I was first diagnosed with a stage 4 neuroendocrine tumor in my small intestine, I went through three stages of coping with my cancer: anger, planning and living life.

Trial Underway to Assess Efficacy of Novel Radiopharmaceutical Drug in Neuroendocrine Tumors

January 5th 2022, 10:00pm

Article

The phase 3 COMPOSE trial will look at the efficacy of using 177lu-edotreotide — a novel radiopharmaceutical that is designed to limit radiation exposure to normal tissue — in patients with later stage neuroendocrine tumors.

Patients With Neuroendocrine Tumors May ‘Achieve the Cure’ With Liver-Directed Therapies

December 13th 2021, 4:00pm

Article

For patients with neuroendocrine tumors that have spread, curating a liver-directed approach may make their treatment process less risky and less invasive, according to an expert.

The Importance of Neuroendocrine Tumor Imaging

December 1st 2021, 2:00pm

Article

Catching tumors through imaging at an early stage can help guide treatment decisions and may improve a patient’s quality of life — which is why it’s important for patients to stay educated on their options.

The Devastating Experience of Finding Out Your Child Has a Rare Cancer: Part 2

September 24th 2021, 5:00pm

Podcast

It is vital to find support when your child has cancer. In this two-part episode of the “CURE® Talks Cancer” podcast, a family shares how they were able to remain strong as their 9-year-old was treated for neuroendocrine cancer.

The Devastating Experience of Finding Out Your Child Has a Rare Cancer: Part 1

September 23rd 2021, 3:00pm

Podcast

Where do you turn when your child is diagnosed with a rare cancer? In this two-part episode of the “CURE® Talks Cancer” podcast, a family shares the harrowing experience of learning their nine-year-old had neuroendocrine cancer.

Inlyta-Synthetic Hormone Combo Fails to Significantly Improve Survival Outcome in Pancreatic Neuroendocrine Tumors

January 20th 2021, 2:00pm

Article

The combination of Inlyta (axitinib) and the synthetic hormone octreotide acetate failed to significantly improve progression-free survival, compared to placebo with the synthetic hormone. However, the results indicated the Inlyta-based combination did improve disease response in patients versus the placebo-based combination.